Company Filing History:
Years Active: 2020-2025
Title: Edward Geissler: Innovator in Cancer Diagnosis and Treatment
Introduction
Edward Geissler is a notable inventor based in Wuppertal, Germany. He has made significant contributions to the field of cancer diagnosis and treatment through his innovative research and inventions. With a total of 2 patents, Geissler's work focuses on the plasma membrane citrate transporter and its applications in oncology.
Latest Patents
Geissler's latest patents include a method for the diagnosis of cancer involving the plasma membrane citrate transporter (pmCiC). This invention is directed towards utilizing pmCiC as a tumor marker and includes a modified substrate or modulator of pmCiC. The method also encompasses screening for a modulator of pmCiC activity, which could enhance cancer diagnosis and treatment strategies.
Career Highlights
Edward Geissler is affiliated with Universitätsklinikum Regensburg, where he conducts his research. His work has been instrumental in advancing the understanding of cancer biology and developing new diagnostic methods. Geissler's innovative approach has positioned him as a key figure in the medical research community.
Collaborations
Geissler collaborates with esteemed colleagues such as Maria Mycielska and Petra Rümmele. Their combined expertise contributes to the advancement of research in cancer diagnostics and treatment.
Conclusion
Edward Geissler's contributions to cancer diagnosis and treatment through his patents and research are commendable. His work continues to pave the way for innovative solutions in the medical field.